Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50014637
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145527((S)-5-{4-[3-(5-Fluoro-1,4,5,6-tetrahydro-pyrimidin...)
Affinity DataIC50: 0.0550nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145533((S)-2-Benzyloxycarbonylamino-5-oxo-5-{4-[3-(4,5,6,...)
Affinity DataIC50: 0.0560nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145528((S)-2-Benzyloxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,...)
Affinity DataIC50: 0.0580nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145530((S)-2-Benzyloxycarbonylamino-5-{4-[3-(5-fluoro-1,4...)
Affinity DataIC50: 0.0630nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145526((S)-2-Benzyloxycarbonylamino-5-{4-[3-(5-hydroxy-1,...)
Affinity DataIC50: 0.150nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145525(2-Benzyloxycarbonylamino-5-{4-[3-(4,5-dihydro-1H-i...)
Affinity DataIC50: 0.160nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145523((S)-5-Oxo-5-{4-[3-(1,4,5,6-tetrahydro-pyrimidin-2-...)
Affinity DataIC50: 0.220nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145522((S)-5-{4-[3-(5-Hydroxy-1,4,5,6-tetrahydro-pyrimidi...)
Affinity DataIC50: 0.300nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145529((S)-2-Isobutoxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,...)
Affinity DataIC50: 0.320nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145532((S)-5-{4-[3-(5,5-Dimethyl-1,4,5,6-tetrahydro-pyrim...)
Affinity DataIC50: 0.380nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145524((S)-2-Ethoxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,6-t...)
Affinity DataIC50: 0.590nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145520((S)-2-Benzenesulfonylamino-5-oxo-5-{4-[3-(1,4,5,6-...)
Affinity DataIC50: 1.40nMAssay Description:Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145521((S)-2-(3-Benzyl-ureido)-5-oxo-5-{4-[3-(1,4,5,6-tet...)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145531((S)-2-(3-Ethyl-ureido)-5-oxo-5-{4-[3-(1,4,5,6-tetr...)
Affinity DataIC50: 3.60nMAssay Description:Inhibition of binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145534((S)-5-Oxo-2-phenylacetylamino-5-{4-[3-(1,4,5,6-tet...)
Affinity DataIC50: 6.80nMAssay Description:Inhibition of binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145523((S)-5-Oxo-5-{4-[3-(1,4,5,6-tetrahydro-pyrimidin-2-...)
Affinity DataIC50: 30nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145520((S)-2-Benzenesulfonylamino-5-oxo-5-{4-[3-(1,4,5,6-...)
Affinity DataIC50: 88nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145526((S)-2-Benzyloxycarbonylamino-5-{4-[3-(5-hydroxy-1,...)
Affinity DataIC50: 340nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145530((S)-2-Benzyloxycarbonylamino-5-{4-[3-(5-fluoro-1,4...)
Affinity DataIC50: 540nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145528((S)-2-Benzyloxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,...)
Affinity DataIC50: 660nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145525(2-Benzyloxycarbonylamino-5-{4-[3-(4,5-dihydro-1H-i...)
Affinity DataIC50: 720nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145529((S)-2-Isobutoxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145534((S)-5-Oxo-2-phenylacetylamino-5-{4-[3-(1,4,5,6-tet...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145524((S)-2-Ethoxycarbonylamino-5-oxo-5-{4-[3-(1,4,5,6-t...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145533((S)-2-Benzyloxycarbonylamino-5-oxo-5-{4-[3-(4,5,6,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145522((S)-5-{4-[3-(5-Hydroxy-1,4,5,6-tetrahydro-pyrimidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145527((S)-5-{4-[3-(5-Fluoro-1,4,5,6-tetrahydro-pyrimidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145531((S)-2-(3-Ethyl-ureido)-5-oxo-5-{4-[3-(1,4,5,6-tetr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145521((S)-2-(3-Benzyl-ureido)-5-oxo-5-{4-[3-(1,4,5,6-tet...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dainippon Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50145532((S)-5-{4-[3-(5,5-Dimethyl-1,4,5,6-tetrahydro-pyrim...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity was determined against human alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed